Recruiting studies: Patients With Irritable Bowel Syndrome With Diarrhea

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Phase 2/Phase 3 · 1 location(s) · Md. Hazrat Ali · NCT07114055 Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Phase 3 · 10 location(s) · Biocodex · NCT07168434 Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NA · 12 location(s) · Devintec Sagl · NCT06681012 The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gast
NA · 1 location(s) · Nimble Science Ltd. · NCT06317441 Effects of the Multispecies Probiotic Ecologic Barrier in IBS Patients With Upper GI Symptoms and Anxiety, Depression, o
NA · 1 location(s) · Institute of Gastroenterology and Hepatology, Vietnam · NCT07656623 Efficacy of Rifaximin With NAC in IBS-D
Phase 2 · 1 location(s) · Mark Pimentel, MD · NCT06727422 A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
Phase 3 · 2 location(s) · Guangzhou Zhiyi Biotechnology Co., Ltd. · NCT06247046

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.